A carregar...
Sorafenib in Metastatic Thyroid Cancer: A Systematic Review
BACKGROUND. Sorafenib was recently approved by the U.S. Food and Drug Administration for radioiodine-resistant metastatic differentiated thyroid cancer (DTC). In addition, two drugs (vandetanib and cabozantinib) have received U.S. Food and Drug Administration approval for use in medullary thyroid ca...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3958462/ https://ncbi.nlm.nih.gov/pubmed/24563075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0362 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|